Derma Sciences raises $29M, as CEO claims diabetic foot ulcer agent could be global $900M drug
23 June 2011
Nancy Faigen
Please Login to read the full article.
23 June 2011
Nancy Faigen
nNancy.faigen@informausa.com
Please Login to read the full article.
RELATED CONTENT
NEWS
- Express Scripts $29.1 billion bid for Medco will hit US FTC scrutiny and squeeze pharma
- AMAG, Allos to merge – but will it really bring sales synergies for Feraheme, Folotyn?
- InSite to raise $22M to advance PhIII pipeline including combo product for lid margin disease
- Allos' Folotyn extends PFS and defers resistance to other drugs in lymphoma
